Clinical Trial Detail

NCT ID NCT01052363
Title OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors West Virginia University
Indications

astrocytoma

oligodendroglioma

glioblastoma multiforme

malignant glioma

Therapies

Bevacizumab + Fosbretabulin

Age Groups: adult

No variant requirements are available.